XML 81 R54.htm IDEA: XBRL DOCUMENT
v3.20.4

Capital Management (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2020
Corporate Information And Statement Of IFRS Compliance [Abstract] |
Schedule of Total Capital | For regulatory reporting purposes under the LICAT framework, there were further adjustments, including goodwill, non-life investments, and others as was prescribed by OSFI, to the total capital figure presented in the table below:
As at December 31, | 2020 | 2019
Subordinated debt |  | $ | 4,781 |  |  | $ | 3,538 |
Innovative capital instruments(1) |  | 200 |  |  | 200 |
Equity: |  |  |  |
Preferred shareholders’ equity |  | 2,257 |  |  | 2,257 |
Common shareholders’ equity |  | 22,212 |  |  | 21,141 |
Participating policyholders’ equity |  | 1,368 |  |  | 1,091 |
Non-controlling interests’ equity |  | 25 |  |  | 19 |
Total capital |  | $ | 30,843 |  |  | $ | 28,246 |
(1) Innovative capital instruments are SLEECS issued by SLCT I (Note 13). SLCT I is not consolidated by us.

X
- Definition Corporate Information And Statement Of IFRS Compliance [Abstract] + References No definition available. + Details
Name: | slf_CorporateInformationAndStatementOfIFRSComplianceAbstract
Namespace Prefix: | slf_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Disclosure Of Total Capital [Table Text Block] + References No definition available. + Details
Name: | slf_DisclosureOfTotalCapitalTableTextBlock
Namespace Prefix: | slf_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration